ReviewCancers2023

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer.

Giuseppe Schepisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.